Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-04-21
1996-11-12
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514547, 514549, 514558, 514560, A61K 3122, A61K 31225, A61K 3119, A61K 3120
Patent
active
055740650
ABSTRACT:
The present invention provides a lipid composition and method that limits the injury response in patients suffering trauma, burns, and/or sepsis. The composition includes: medium chain triglycerides; a source of omega-6 fatty acids; and a source of omega-3 fatty acids. The composition can be administered alone or in combination with other nutrients. The composition can be administered enterally or parenterally.
REFERENCES:
patent: 4670285 (1987-06-01), Clandinin et al.
patent: 4678808 (1987-07-01), Ward et al.
patent: 4752618 (1988-06-01), Mascioli et al.
patent: 4804366 (1989-02-01), Zdeb et al.
patent: 4820731 (1989-04-01), Mascioli et al.
patent: 4847296 (1989-07-01), Babayan et al.
patent: 4871768 (1989-10-01), Bistrian et al.
patent: 5034414 (1991-07-01), Wakabayashi et al.
patent: 5053387 (1991-10-01), Alexander
patent: 5089268 (1992-02-01), Katz
patent: 5308832 (1994-05-01), Garleb et al.
Aggett, P. J.: "Comment on the Content and Composition of Lipids in Infant Formulas," in Acta Pediatric Scand 80: pp. 887-896, 1991.
Carlson, Susan E. et al.: "Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation.sup.1-3 " in American Journal of Clinical Nutrition, vol. 58, pp. 35-42, 1993.
Clandinin, M. T. et al.: "Requirements of Newborn Infants for Long Chain Polyunsaturated Fatty Acids," in Acta Pediatric Scand 351: pp. 63-71, 1989.
Clark, Kristin J. et al.: "Determination of the optimal ratio of linoleic acid to .alpha.-linolenic acid in infant formulas," in The Journal of Pediatrics, Apr. 1992, pp. S151-S158.
Goulet, O. et al.: "Long Term Utilization of a .gamma.-Linolenic Acid Enriched Intravenous Fat Emulsion in Children," in Clinical Nutrition, vol. 12, Supplement 2, 1993, p. 25.
Hariz, M. Ben et al.: "Bone Mass During Long Term Parenteral Nutrition in Children," in Clinical Nutrition, vol. 12, Supplement 2, 1993, p. 25.
Hoffman, Dennis R. et al.: "Effects of supplementation with .omega.3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants.sup.1-3 ", in American Journal of Clinical Nutrition, vol. 57 (suppl), pp. 807S-812S, 1993.
Hoffman, Dennis R. et al.: "Essentially of Dietary .omega.3 Fatty Acids for Premature Infants: Plasma and Red Blood Cell Fatty Acid Composition," in Lipids, vol. 27, No. 11, pp. 886-895, 1992.
Innis, Sheila M.: "n-3 Fatty Acid Requirements of the Newborn," in Lipids, vol. 27, No. 11, pp. 879-885, 1992.
Koletzko, B. et al.: "Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants," in European Journal of Pediatrics, vol. 148, pp. 669-675, 1989.
Martinez, Manuela et al.: "Effects of Parenteral Nutrition with High Doses of Linoleate on the Developing Human Liver and Brain," in Lipids, vol. 22, No. 3, pp. 133-138, 1987.
Munck, A. et al.: "Comparison of Fatty Acid Status in TPN-dependent Children Receiving Two Lipid Emulsions with Different Essential Fatty Acids (EFA) Content," in Clinical Nutrition, vol. 12, Supplement 2, 1993, p. 25.
Neuringer, Martha et al.: "The Essentiality of N-3 Fatty Acids for the Development and Function of the Retina and Brain," in Ann. Rev. Nutr., vol. 8, pp. 517-541, 1988.
Salem, Jr., N. and Pawlosky, R. J.: "Docosahexaenoic Acid is an Essential Nutrient in the Nervous System," in J Nutr Sci Vitaminol, pp. 153-156, 1992.
Barton, MD, Richard G., et al.: "Dietary Omega-3 Fatty Acids Decrease Mortality and Kupffer Cell Prostaglandin E.sub.2 Production in a Rat Model of Chronic Sepsis," The Journal of Trauma, vol. 31, No. 6, 1991, pp. 768-774.
Billiar, MD, T. R., et al.: "Fatty Acid Intake and Kupffer Cell Function: Fish Oil Alters Eicosanoid and Monokine Production to Endotoxin Stimuation," Surgery, Aug. 1988, pp. 343-349.
Boudreau, Mary D. et al.: "Lack of Dose Response by Dietary n-3 Fatty Acids at a Constant Ration of n-3 to n-6 Fatty acids in Suppressing Eicosanoid Biosynthese from Arachidonic acid.sup.1-3," Am J. Clin. Nutr., 1991; vol. 54, pp. 111-117.
Broughton, K. Shane et al.: "Effect of Increasing the Dietary (n-3) to (n-6) Polyunsaturated Fatty Acid Ratio on Murine Liver and Peritoneal Cell Fatty Acids and Eicosanoid Formation.sup.1,2," American Institute of Nutrition, 1991, pp. 155-164.
Hellerstein, Marc K. et al.: "Interleukin 1-induced Anorexia in the Rat--Influence of Prostaglandins," J. Clin. Invest., vol. 84, Jul. 1989, pp. 228-235.
Hirschberg, Yulia et al.: "The Effects of Chronic Fish Oil Feeding in Rats on Protein Catabolism Induced by Recombinant Mediators," Metabolism, vol. 39, No. 4, apr. 1990, pp. 397-402.
Mascioli, Edward et al.: "Endotoxin Challenge After Menhaden Oil Diet: Effects on Survival of Guinea Pigs," Am J Clin Nutr, vol. 49, 1989, pp. 277-282.
Mascioli, Edward et al.: "Enhanced Survival to Endotoxin in Guinea Pigs Fed IV Fish Oil Emulsion," Lipids, vol. 23, No. 6, 1988, pp. 623-625.
Ogle, C. K. et al.: "An Evaluation of the Effect of Eicosapentaenoic Acid in the Diet on Macrophage PGE Production and Lymphocyte Proliferation in a Burned Guinea Pig Model," Clinical Nutrition, vol. 7, 1988, pp. 219-223.
Pomposelli, James J. et al.: "Attenuation of the Febrile Response in Guinea Pigs by Fish Oil Enriched Diets," Journal of Parenteral and Enteral Nutrition, vol. 13, No. 2, 1989, pp. 136-140.
Swenson, E. Scott et al.: "Persistence of Metabolic Effects After Long-Term Oral Feeding of a Structured Triglyceride Derived from Medium-Chain Triglyceride and Fish Oil in Burned and Normal Rats," Metabolism, vol. 40, No. 5, May 1991, pp. 484-490.
Teo, MD, T. C. et al.: "Administration of Structured Lipid Composed of MCT and Fish Oil Reduces Net Protein Catabolism in Enterally Fed Burned Rats," Ann. Surg., vol. 210, No. 1, Jul. 1989, pp. 100-107.
Clintec Nutrition Co.
Weddington Kevin E.
LandOfFree
Method and composition for normalizing injury response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for normalizing injury response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for normalizing injury response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-563001